| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 7.860 | 13.474 | 22.506 | 14.730 | 35.356 | 31.390 | 23.441 | 22.347 |
| Total Income - EUR | 0 | 0 | 7.860 | 13.474 | 22.506 | 14.758 | 35.473 | 31.428 | 23.456 | 22.797 |
| Total Expenses - EUR | 596 | 5.078 | 2.332 | 6.484 | 4.982 | 2.833 | 1.991 | 1.797 | 1.993 | 3.330 |
| Gross Profit/Loss - EUR | -596 | -5.078 | 5.528 | 6.989 | 17.524 | 11.926 | 33.482 | 29.631 | 21.462 | 19.468 |
| Net Profit/Loss - EUR | -596 | -5.078 | 5.292 | 6.585 | 16.849 | 11.499 | 32.439 | 28.707 | 18.441 | 16.410 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Albor Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 40 | 0 | 0 | 0 | 0 | 0 | 471 | 174 | 0 | 0 |
| Current Assets | 31 | -5.554 | 146 | 6.354 | 18.103 | 51.532 | 33.300 | 28.863 | 23.983 | 17.476 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 2.065 | 1.488 | 3.629 | 1.947 | 2.749 | 181 |
| Cash | 31 | -5.554 | 146 | 6.354 | 16.038 | 33.683 | 13.562 | 26.917 | 21.233 | 17.295 |
| Shareholders Funds | -551 | -5.623 | -236 | 6.354 | 17.756 | 51.200 | 32.488 | 28.756 | 22.937 | 16.458 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 622 | 69 | 382 | 0 | 347 | 332 | 1.283 | 282 | 1.045 | 1.018 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Albor Medical Srl